Circulating microRNA: A new candidate for diagnostic biomarker in neuroblastoma

M. Mohammadi; M. Goodarzi; M. R. Jaafari; H. R. Mirzaei; H. Mirzaei

doi:10.1038/cgt.2016.45

Circulating microRNA: A new candidate for diagnostic biomarker in neuroblastoma

M. Mohammadi, M. Goodarzi, M. R. Jaafari, H. R. Mirzaei, H. Mirzaei

Research output: Contribution to journal › Article › peer-review

95 Scopus citations

Abstract

Neuroblastoma (NB) is known as a pediatric neoplasm that is associated with variable histopathological features. The use of biomarkers contributes to the monitoring and treatment of various malignancies such as NB. The identification of novel biomarkers such as (epi)genetic biomarkers and microRNAs (miRNAs) in NB has led to better treatments of NB. Among them, miRNAs have emerged as powerful tools in diagnosis, prognosis and therapeutic biomarkers for patients with NB. Circulating biomarkers such as circulating miRNAs present in body fluids (for example, plasma, serum and urine) provided an interesting field of study in NB treatment. The miRNAs have central roles in different pathogenic events in various malignancies such as NB. Hence, these molecules can be a suitable candidate for monitoring and treating NB patients. Here, we summarize some miRNAs as potential prognosis, diagnosis and therapeutic biomarkers in NB.

Original language	English (US)
Pages (from-to)	371-372
Number of pages	2
Journal	Cancer Gene Therapy
Volume	23
Issue number	11
DOIs	https://doi.org/10.1038/cgt.2016.45
State	Published - Nov 1 2016

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Cancer Research

Access to Document

10.1038/cgt.2016.45

Cite this

@article{766052f8f71341f49101c6da4ebfaf34,

title = "Circulating microRNA: A new candidate for diagnostic biomarker in neuroblastoma",

abstract = "Neuroblastoma (NB) is known as a pediatric neoplasm that is associated with variable histopathological features. The use of biomarkers contributes to the monitoring and treatment of various malignancies such as NB. The identification of novel biomarkers such as (epi)genetic biomarkers and microRNAs (miRNAs) in NB has led to better treatments of NB. Among them, miRNAs have emerged as powerful tools in diagnosis, prognosis and therapeutic biomarkers for patients with NB. Circulating biomarkers such as circulating miRNAs present in body fluids (for example, plasma, serum and urine) provided an interesting field of study in NB treatment. The miRNAs have central roles in different pathogenic events in various malignancies such as NB. Hence, these molecules can be a suitable candidate for monitoring and treating NB patients. Here, we summarize some miRNAs as potential prognosis, diagnosis and therapeutic biomarkers in NB.",

author = "M. Mohammadi and M. Goodarzi and Jaafari, {M. R.} and Mirzaei, {H. R.} and H. Mirzaei",

year = "2016",

month = nov,

day = "1",

doi = "10.1038/cgt.2016.45",

language = "English (US)",

volume = "23",

pages = "371--372",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Circulating microRNA

T2 - A new candidate for diagnostic biomarker in neuroblastoma

AU - Mohammadi, M.

AU - Goodarzi, M.

AU - Jaafari, M. R.

AU - Mirzaei, H. R.

AU - Mirzaei, H.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Neuroblastoma (NB) is known as a pediatric neoplasm that is associated with variable histopathological features. The use of biomarkers contributes to the monitoring and treatment of various malignancies such as NB. The identification of novel biomarkers such as (epi)genetic biomarkers and microRNAs (miRNAs) in NB has led to better treatments of NB. Among them, miRNAs have emerged as powerful tools in diagnosis, prognosis and therapeutic biomarkers for patients with NB. Circulating biomarkers such as circulating miRNAs present in body fluids (for example, plasma, serum and urine) provided an interesting field of study in NB treatment. The miRNAs have central roles in different pathogenic events in various malignancies such as NB. Hence, these molecules can be a suitable candidate for monitoring and treating NB patients. Here, we summarize some miRNAs as potential prognosis, diagnosis and therapeutic biomarkers in NB.

AB - Neuroblastoma (NB) is known as a pediatric neoplasm that is associated with variable histopathological features. The use of biomarkers contributes to the monitoring and treatment of various malignancies such as NB. The identification of novel biomarkers such as (epi)genetic biomarkers and microRNAs (miRNAs) in NB has led to better treatments of NB. Among them, miRNAs have emerged as powerful tools in diagnosis, prognosis and therapeutic biomarkers for patients with NB. Circulating biomarkers such as circulating miRNAs present in body fluids (for example, plasma, serum and urine) provided an interesting field of study in NB treatment. The miRNAs have central roles in different pathogenic events in various malignancies such as NB. Hence, these molecules can be a suitable candidate for monitoring and treating NB patients. Here, we summarize some miRNAs as potential prognosis, diagnosis and therapeutic biomarkers in NB.

UR - http://www.scopus.com/inward/record.url?scp=84991037520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991037520&partnerID=8YFLogxK

U2 - 10.1038/cgt.2016.45

DO - 10.1038/cgt.2016.45

M3 - Article

C2 - 27740613

AN - SCOPUS:84991037520

SN - 0929-1903

VL - 23

SP - 371

EP - 372

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 11

ER -

Circulating microRNA: A new candidate for diagnostic biomarker in neuroblastoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this